Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 4
1978 2
1981 3
1983 3
1985 1
1986 1
1987 3
1988 3
1989 1
1991 4
1992 5
1993 2
1994 4
1995 3
1996 5
1997 2
1998 7
1999 8
2000 4
2001 8
2002 11
2003 7
2004 14
2005 15
2006 23
2007 31
2008 44
2009 56
2010 41
2011 44
2012 46
2013 48
2014 27
2015 38
2016 57
2017 60
2018 57
2019 75
2020 60
2021 29
Text availability
Article attribute
Article type
Publication date

Search Results

771 results
Results by year
Filters applied: . Clear all
Page 1
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV; TOURMALINE-MM3 study group. Dimopoulos MA, et al. Among authors: dash ab. Lancet. 2019 Jan 19;393(10168):253-264. doi: 10.1016/S0140-6736(18)33003-4. Epub 2018 Dec 10. Lancet. 2019. PMID: 30545780 Clinical Trial.
Non-alcoholic fatty liver disease (NAFLD) models in drug discovery.
Cole BK, Feaver RE, Wamhoff BR, Dash A. Cole BK, et al. Among authors: dash a. Expert Opin Drug Discov. 2018 Feb;13(2):193-205. doi: 10.1080/17460441.2018.1410135. Epub 2017 Dec 6. Expert Opin Drug Discov. 2018. PMID: 29190166 Review.
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML.
Swords RT, Coutre S, Maris MB, Zeidner JF, Foran JM, Cruz J, Erba HP, Berdeja JG, Tam W, Vardhanabhuti S, Pawlikowska-Dobler I, Faessel HM, Dash AB, Sedarati F, Dezube BJ, Faller DV, Savona MR. Swords RT, et al. Among authors: dash ab. Blood. 2018 Mar 29;131(13):1415-1424. doi: 10.1182/blood-2017-09-805895. Epub 2018 Jan 18. Blood. 2018. PMID: 29348128 Free PMC article. Clinical Trial.
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.
Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Kibel AS, Shemanski L, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS, Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Venkatramani V, Soodana-Prakash N, Kendrick K, Smith JA Jr, Thompson IM. Parekh DJ, et al. Among authors: dash a. Lancet. 2018 Jun 23;391(10139):2525-2536. doi: 10.1016/S0140-6736(18)30996-6. Lancet. 2018. PMID: 29976469 Clinical Trial.
Peptide receptor radionuclide therapy: an overview.
Dash A, Chakraborty S, Pillai MR, Knapp FF Jr. Dash A, et al. Cancer Biother Radiopharm. 2015 Mar;30(2):47-71. doi: 10.1089/cbr.2014.1741. Epub 2015 Feb 24. Cancer Biother Radiopharm. 2015. PMID: 25710506 Review.
771 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page